Conavi Medical Corp (Conavi), formerly Titan Medical Inc, is a medical device company specializing in imaging technologies for minimally invasive cardiovascular procedures. The company's lead product, the Novasight Hybrid System, is the first device to combine intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single system, enabling simultaneous, co-registered imaging of coronary arteries. This system has received regulatory approval from the US Food and Drug Administration, Health Canada, China's National Medical Products Administration, and Japan’s Ministry of Health, Labor, and Welfare. The Novasight Hybrid System is designed for use in coronary artery procedures, offering superior imaging capabilities without the trade-offs typically associated with combining different modalities. It allows clinicians to select between IVUS-OCT hybrid pullbacks for comprehensive imaging or IVUS-only imaging for specific needs, such as aorto-ostial lesion assessment or real-time lesion surveys. The system is equipped with single-use IVUS OCT catheters and a unified console, which reduces costs, conserves cath lab space, and simplifies equipment selection.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.